Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Adalimumab> ?p ?o. }
Showing items 1 to 89 of
89
with 100 items per page.
- Adalimumab abstract "Adalimumab, trade name Humira, is a TNF inhibiting anti-inflammatory drug. AbbVie's trade name is derived from the acronym of "human monoclonal antibody in rheumatoid arthritis" (HUMIRA). Adalimumab binds to tumor necrosis factor-alpha (TNFα), preventing it from activating TNF receptors; TNFα inactivation has proven to be important in downregulating the inflammatory reactions associated with autoimmune diseases. Adalimumab has been approved in the United States for rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, moderate to severe chronic psoriasis and juvenile idiopathic arthritis.In rheumatoid arthritis, adalimumab has a response rate similar to methotrexate, and in combination nearly doubles the response rate of methotrexate alone.Because TNFα is part of the immune system that protects the body from infection, treatment with adalimumab may increase the risk of infections.It is marketed in 0.8 mL vials, preloaded 0.8 mL syringes and also in preloaded pen devices (called Humira Pen), injected subcutaneously, typically by the patient at home. It cannot be administered orally because the digestive system would destroy the drug.[citation needed]Adalimumab was the first fully human monoclonal antibody drug approved by the FDA. It was derived from phage display, and was discovered through a collaboration between BASF Bioresearch Corporation (Worcester, Massachusetts, a unit of BASF) and Cambridge Antibody Technology as D2E7, then further manufactured at BASF Bioresearch Corporation and developed by BASF Knoll (BASF Pharma) and, ultimately, manufactured and marketed by Abbott Laboratories after the acquisition of BASF Pharma by Abbott.Humira costs approximately $1,662 per month, like the TNF-alpha inhibitor etanercept (Enbrel). Methotrexate costs approximately $13 to $85 per month.In 2012 Humira drug had $4.3 billion of sales in the US, and $9.3 billion worldwide.".
- Adalimumab atcPrefix "L04".
- Adalimumab atcSuffix "AB04".
- Adalimumab bioavailability "64.0".
- Adalimumab casNumber "331731-18-1".
- Adalimumab drugbank "DB00051".
- Adalimumab fdaUniiCode "FYS6T7F842".
- Adalimumab thumbnail Adalimumab_structure.png?width=300.
- Adalimumab wikiPageExternalLink www.drugcite.com?q=HUMIRA.
- Adalimumab wikiPageExternalLink views?hl=en&safe=off&q=humira++view%3Atimeline&btnG=Search.
- Adalimumab wikiPageExternalLink www.humira.com.
- Adalimumab wikiPageID "1829708".
- Adalimumab wikiPageRevisionID "605454045".
- Adalimumab atcPrefix "L04".
- Adalimumab atcSuffix "AB04".
- Adalimumab bioavailability "64".
- Adalimumab c "6428".
- Adalimumab casNumber "331731".
- Adalimumab chembl "1201580".
- Adalimumab chemspiderid "NA".
- Adalimumab drugbank "DB00051".
- Adalimumab eliminationHalfLife "10".
- Adalimumab h "9912".
- Adalimumab hasPhotoCollection Adalimumab.
- Adalimumab kegg "D02597".
- Adalimumab legalUk "POM".
- Adalimumab legalUs "Rx-only".
- Adalimumab mabType "mab".
- Adalimumab medlineplus "a603010".
- Adalimumab molecularWeight "144190.3".
- Adalimumab n "1694".
- Adalimumab o "1987".
- Adalimumab pregnancyAu "C".
- Adalimumab pregnancyUs "B".
- Adalimumab routesOfAdministration Subcutaneous_injection.
- Adalimumab s "46".
- Adalimumab source "u".
- Adalimumab target Tumor_necrosis_factor_alpha.
- Adalimumab tradename "Humira".
- Adalimumab type "mab".
- Adalimumab unii "FYS6T7F842".
- Adalimumab verifiedfields "changed".
- Adalimumab verifiedrevid "477241856".
- Adalimumab subject Category:Immunosuppressants.
- Adalimumab subject Category:Monoclonal_antibodies.
- Adalimumab subject Category:TNF_inhibitors.
- Adalimumab type Agent114778436.
- Adalimumab type CausalAgent100007347.
- Adalimumab type Drug103247620.
- Adalimumab type Immunosuppressant103562958.
- Adalimumab type Immunosuppressants.
- Adalimumab type Inhibitor114724436.
- Adalimumab type Matter100020827.
- Adalimumab type Medicine103740161.
- Adalimumab type PhysicalEntity100001930.
- Adalimumab type Substance100020090.
- Adalimumab type TNF-alphaInhibitors.
- Adalimumab type Drug.
- Adalimumab type DrugProduct.
- Adalimumab type FunctionalSubstance.
- Adalimumab comment "Adalimumab, trade name Humira, is a TNF inhibiting anti-inflammatory drug. AbbVie's trade name is derived from the acronym of "human monoclonal antibody in rheumatoid arthritis" (HUMIRA). Adalimumab binds to tumor necrosis factor-alpha (TNFα), preventing it from activating TNF receptors; TNFα inactivation has proven to be important in downregulating the inflammatory reactions associated with autoimmune diseases.".
- Adalimumab label "Adalimumab".
- Adalimumab label "Adalimumab".
- Adalimumab label "Adalimumab".
- Adalimumab label "Adalimumab".
- Adalimumab label "Adalimumab".
- Adalimumab label "Adalimumab".
- Adalimumab label "Adalimumab".
- Adalimumab label "Adalimumabe".
- Adalimumab label "أداليموماب".
- Adalimumab label "アダリムマブ".
- Adalimumab sameAs Adalimumab.
- Adalimumab sameAs Adalimumab.
- Adalimumab sameAs Adalimumab.
- Adalimumab sameAs Adalimumab.
- Adalimumab sameAs アダリムマブ.
- Adalimumab sameAs Adalimumab.
- Adalimumab sameAs Adalimumab.
- Adalimumab sameAs Adalimumabe.
- Adalimumab sameAs m.05_9rs.
- Adalimumab sameAs Q348260.
- Adalimumab sameAs Q348260.
- Adalimumab sameAs adalimumab.
- Adalimumab sameAs DB00051.
- Adalimumab sameAs Adalimumab.
- Adalimumab wasDerivedFrom Adalimumab?oldid=605454045.
- Adalimumab depiction Adalimumab_structure.png.
- Adalimumab homepage www.humira.com.
- Adalimumab isPrimaryTopicOf Adalimumab.